Fibromyalgia and associated factors in patients with axial spondyloarthritis: The effect of fibromyalgia on disease activity

[1]  Ruoxi Gao.  Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis , 2021, Journal of musculoskeletal & neuronal interactions.

[2]  A. Iagnocco,et al.  Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey , 2021, RMD Open.

[3]  S. Dogra,et al.  Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis , 2021, Rheumatology International.

[4]  O. Elkana,et al.  Physical and mental impact of COVID-19 outbreak on fibromyalgia patients. , 2021, Clinical and experimental rheumatology.

[5]  J. S. Lee,et al.  Fibromyalgia in Axial Spondyloarthritis , 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[6]  G. Macfarlane,et al.  The changing states of fibromyalgia in patients with axial spondyloarthritis: results from BSRBR-AS. , 2020, Rheumatology.

[7]  A. Moltó,et al.  Comorbid pain in axial spondyloarthritis, including fibromyalgia , 2020, Therapeutic advances in musculoskeletal disease.

[8]  F. Ayhan,et al.  The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study , 2020, Modern rheumatology.

[9]  F. Yurdakul,et al.  Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies , 2020, Rheumatology International.

[10]  M. Magrey,et al.  The American College of Rheumatology Fibromyalgia Criteria Are Useful in the Evaluation of Fibromyalgia Symptoms in Patients With Ankylosing Spondylitis , 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[11]  M. Elshahaly,et al.  Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis , 2019, Rheumatology International.

[12]  N. Goodson,et al.  The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. , 2019, Best practice & research. Clinical rheumatology.

[13]  G. Littlejohn,et al.  Faculty Opinions recommendation of 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[14]  M. Dougados,et al.  Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study , 2017, Annals of the rheumatic diseases.

[15]  Philip J Mease,et al.  2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.

[16]  J. Tebib,et al.  Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice , 2016, The Journal of Rheumatology.

[17]  M. Dougados,et al.  Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis , 2016, Arthritis Research & Therapy.

[18]  F. Salaffi,et al.  Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity , 2014, Rheumatology International.

[19]  F. Atamaz,et al.  Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire , 2013, Rheumatology International.

[20]  L. Carmona,et al.  Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. , 2010, Clinical and experimental rheumatology.

[21]  M. Dougados,et al.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection , 2009, Annals of the rheumatic diseases.

[22]  M. Dougados,et al.  Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis , 2008, Annals of the rheumatic diseases.

[23]  S. Akar,et al.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity , 2005, Rheumatology International.

[24]  S. Akar,et al.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity , 2005, Rheumatology International.

[25]  F. Wolfe,et al.  Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. , 2004, The Journal of rheumatology.

[26]  A. Calin,et al.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. , 1994, The Journal of rheumatology.

[27]  A. Calin,et al.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.

[28]  R M Bennett,et al.  The fibromyalgia impact questionnaire: development and validation. , 1991, The Journal of rheumatology.